Disrupting Drug Discovery From Assay Development to Lead Compound

Download the Whitepaper

High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery.

In this whitepaper, SAMDI Tech CSO, Zack Gurard-Levin, discusses the important aspects to consider when choosing the right methodology for drug discovery.


  • Traditional label-dependent approaches vs. novel label-free technologies
  • How researchers determine which methodology offers the most promising path forward for their target
  • How to take into account assay sensitivity, data quality, costs, and speed
  • When to outsource to contract research organizations with an established discovery infrastructure to lead hit identification and hit-to-lead programs

Learn more here.

Related Articles